Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV)

Latest Posts

Studies estimate 75% RSV vaccine efficacy in older adults, profile risk for poor outcomes​
Hospital admissions of respiratory infections in infants plunge with nirsevimab RSV antibody​
RSV studies identify risk factors in older adults, household transmission routes​
Study shows nirsevimab provides significant protection against RSV​
Nirsevimab estimated at 64% to 74% effective against poor RSV outcomes in infants​
Reports describe good maternal RSV vaccine, drug uptake in their first season​
UK study finds 2% of primary care antibiotic prescriptions were for RSV—a viral illness​
RSV vaccine prompts robust immune response in older recipients over 2 seasons​
US flu activity climbs, with more deaths in kids​
VA study shows COVID more severe than RSV, flu​
Studies look at RSV uptake among veterans, ICU risk factors for older patients​
Quick takes: EMA lifts chikungunya vaccine restriction, another Nipah case from India, expanded indication review for Arexvy​
New data reveal impact of RSV on kids with chronic conditions, plus high adult exposure​
Shingles, RSV vaccines may protect older adults from dementia​
RSV hospitalization in adults tied to risk of death and kidney, heart problems​
ACIP draft agenda revives anti-vaccine boilerplate topics​
Moderna receives expanded approval for RSV vaccine​
FDA approves Merck RSV monoclonal antibody shot for infants​
Flu, RSV linked to higher odds of secondary bacterial infection​
Study details economic impact of RSV infections in young children​